In cases of steroid-refractory irAEs like colitis, pneumonitis, arthritis, and hepatitis, other immunomodulatory treatments such as blocking antibodies against tumor necrosis factor alpha (TNF-α) or interleukin 6 (IL6) were shown to be effective [5,9,10,11]. Here, IL6 is linked to colitis.